Stryker Q4 FY25: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 11, 2026
Revenue$7.17B
+11% year over year
Gross profit$4.63B
65% margin
Operating profit$1.80B
25% margin
Net profit$0.85B
12% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 7.17 | 100% | +11% |
| Med surg & neurotechnology | 4.56 | 64% | +18% |
| Orthopaedics | 2.61 | 36% | +2% |
| Cost of revenue | −2.54 | 35% | |
| Gross profit | 4.63 | 65% margin | +0pp |
| R&D | −0.40 | 5% | +0pp |
| SG&A | −2.23 | 31% | −2pp |
| Other | −0.20 | 3% | +0pp |
| Operating profit | 1.80 | 25% margin | +16pp |
| Interest & other costs | −0.10 | ||
| Tax | −0.86 | ||
| Net profit | 0.85 | 12% margin | +3pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest